4923. The Lancet Commission on the future of care and clinical research in autism.
作者: Catherine Lord.;Tony Charman.;Alexandra Havdahl.;Paul Carbone.;Evdokia Anagnostou.;Brian Boyd.;Themba Carr.;Petrus J de Vries.;Cheryl Dissanayake.;Gauri Divan.;Christine M Freitag.;Marina M Gotelli.;Connie Kasari.;Martin Knapp.;Peter Mundy.;Alex Plank.;Lawrence Scahill.;Chiara Servili.;Paul Shattuck.;Emily Simonoff.;Alison Tepper Singer.;Vicky Slonims.;Paul P Wang.;Maria Celica Ysrraelit.;Rachel Jellett.;Andrew Pickles.;James Cusack.;Patricia Howlin.;Peter Szatmari.;Alison Holbrook.;Christina Toolan.;James B McCauley.
来源: Lancet. 2022年399卷10321期271-334页 4924. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
作者: Arabella S V Stuart.;Robert H Shaw.;Xinxue Liu.;Melanie Greenland.;Parvinder K Aley.;Nick J Andrews.;J C Cameron.;Sue Charlton.;Elizabeth A Clutterbuck.;Andrea M Collins.;Tom Darton.;Tanya Dinesh.;Christopher J A Duncan.;Anna England.;Saul N Faust.;Daniela M Ferreira.;Adam Finn.;Anna L Goodman.;Christopher A Green.;Bassam Hallis.;Paul T Heath.;Helen Hill.;Bryn M Horsington.;Teresa Lambe.;Rajeka Lazarus.;Vincenzo Libri.;Patrick J Lillie.;Yama F Mujadidi.;Ruth Payne.;Emma L Plested.;Samuel Provstgaard-Morys.;Maheshi N Ramasamy.;Mary Ramsay.;Robert C Read.;Hannah Robinson.;Gavin R Screaton.;Nisha Singh.;David P J Turner.;Paul J Turner.;Iason Vichos.;Rachel White.;Jonathan S Nguyen-Van-Tam.;Matthew D Snape.; .
来源: Lancet. 2022年399卷10319期36-49页
Given the importance of flexible use of different COVID-19 vaccines within the same schedule to facilitate rapid deployment, we studied mixed priming schedules incorporating an adenoviral-vectored vaccine (ChAdOx1 nCoV-19 [ChAd], AstraZeneca), two mRNA vaccines (BNT162b2 [BNT], Pfizer-BioNTech, and mRNA-1273 [m1273], Moderna) and a nanoparticle vaccine containing SARS-CoV-2 spike glycoprotein and Matrix-M adjuvant (NVX-CoV2373 [NVX], Novavax).
4930. The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.
作者: Tom H Karlsen.;Nick Sheron.;Shira Zelber-Sagi.;Patrizia Carrieri.;Geoffrey Dusheiko.;Elisabetta Bugianesi.;Rachel Pryke.;Sharon J Hutchinson.;Bruno Sangro.;Natasha K Martin.;Michele Cecchini.;Mae Ashworth Dirac.;Annalisa Belloni.;Miquel Serra-Burriel.;Cyriel Y Ponsioen.;Brittney Sheena.;Alienor Lerouge.;Marion Devaux.;Nick Scott.;Margaret Hellard.;Henkjan J Verkade.;Ekkehard Sturm.;Giulio Marchesini.;Hannele Yki-Järvinen.;Chris D Byrne.;Giovanni Targher.;Aviad Tur-Sinai.;Damon Barrett.;Michael Ninburg.;Tatjana Reic.;Alison Taylor.;Tim Rhodes.;Carla Treloar.;Claus Petersen.;Christoph Schramm.;Robert Flisiak.;Marieta Y Simonova.;Albert Pares.;Philip Johnson.;Alessandro Cucchetti.;Isabel Graupera.;Christos Lionis.;Elisa Pose.;Núria Fabrellas.;Ann T Ma.;Juan M Mendive.;Vincenzo Mazzaferro.;Harry Rutter.;Helena Cortez-Pinto.;Deirdre Kelly.;Robyn Burton.;Jeffrey V Lazarus.;Pere Ginès.;Maria Buti.;Philip N Newsome.;Patrizia Burra.;Michael P Manns.
来源: Lancet. 2022年399卷10319期61-116页 4934. Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial.
作者: Simon J Bowman.;Robert Fox.;Thomas Dörner.;Xavier Mariette.;Athena Papas.;Thomas Grader-Beck.;Benjamin A Fisher.;Filipe Barcelos.;Salvatore De Vita.;Hendrik Schulze-Koops.;Robert J Moots.;Guido Junge.;Janice N Woznicki.;Monika A Sopala.;Wen-Lin Luo.;Wolfgang Hueber.
来源: Lancet. 2022年399卷10320期161-171页
Sjögren's syndrome is an autoimmune disease characterised by dry eyes and mouth, systemic features, and reduced quality of life. There are no disease-modifying treatments. A new biologic, ianalumab (VAY736), with two modes of suppressing B cells, has previously shown preliminary efficacy. This dose-finding trial aimed to assess the safety and efficacy of different subcutaneous doses of ianalumab in patients with moderate to severe primary Sjögren's syndrome.
4935. Strategies and interventions for healthy adolescent growth, nutrition, and development.
作者: Dougal Hargreaves.;Emily Mates.;Purnima Menon.;Harold Alderman.;Delan Devakumar.;Wafai Fawzi.;Geva Greenfield.;Weeam Hammoudeh.;Shanshan He.;Anwesha Lahiri.;Zheng Liu.;Phuong Hong Nguyen.;Vani Sethi.;Haijun Wang.;Lynnette M Neufeld.;George C Patton.
来源: Lancet. 2022年399卷10320期198-210页
Adolescence is a pivotal point in the life course, characterised by transformative physical, cognitive, and emotional growth, an openness to change, and a drive to reshape the social environment. It offers unique opportunities to adopt changes in diet and physical activity that can persist into later life. Yet pre-existing nutritional problems, including micronutrient deficiencies, food insecurity, and poor-quality diets, persist at the same time as adolescents face the rapid emergence of an obesity epidemic. Adolescent growth and nutrition has been largely overlooked in intervention and policy research. Most intervention studies have emphasised micronutrient supplementation, with few taking into account the multiple drivers of adolescent diets. This Series paper highlights that effective interventions and policies will need to cut across sectors; be supported by multifaceted and multilevel policy; and extend across education, health, food systems, social protection, and digital media. Better data standardisation and systems will be essential in coordinating and monitoring these responses. In a context of shifts in planetary ecosystems and commercial drivers, resilient food systems will need to both ensure access to healthy and affordable foods and provide the infrastructure and incentives for continuing physical activity. Intergenerational partnerships with young people will be essential in bringing about transformative change and ensuring that food policies reflect their needs and aspirations.
4936. Food choice in transition: adolescent autonomy, agency, and the food environment.
作者: Lynnette M Neufeld.;Eduardo B Andrade.;Ahna Ballonoff Suleiman.;Mary Barker.;Ty Beal.;Lauren S Blum.;Kathrin M Demmler.;Surabhi Dogra.;Polly Hardy-Johnson.;Anwesha Lahiri.;Nicole Larson.;Christina A Roberto.;Sonia Rodríguez-Ramírez.;Vani Sethi.;Teresa Shamah-Levy.;Sofia Strömmer.;Alison Tumilowicz.;Susie Weller.;Zhiyong Zou.
来源: Lancet. 2022年399卷10320期185-197页
Dietary intake during adolescence sets the foundation for a healthy life, but adolescents are diverse in their dietary patterns and in factors that influence food choice. More evidence to understand the key diet-related issues and the meaning and context of food choices for adolescents is needed to increase the potential for impactful actions. The aim of this second Series paper is to elevate the importance given to adolescent dietary intake and food choice, bringing a developmental perspective to inform policy and programmatic actions to improve diets. We describe patterns of dietary intake, then draw on existing literature to map how food choice can be influenced by unique features of adolescent development. Pooled qualitative data is then combined with evidence from the literature to explore ways in which adolescent development can interact with sociocultural context and the food environment to influence food choice. Irrespective of context, adolescents have a lot to say about why they eat what they eat, and insights into factors that might motivate them to change. Adolescents must be active partners in shaping local and global actions that support healthy eating patterns. Efforts to improve food environments and ultimately adolescent food choice should harness widely shared adolescent values beyond nutrition or health.
4937. Nutrition in adolescent growth and development.
作者: Shane A Norris.;Edward A Frongillo.;Maureen M Black.;Yanhui Dong.;Caroline Fall.;Michelle Lampl.;Angela D Liese.;Mariam Naguib.;Ann Prentice.;Tamsen Rochat.;Charles B Stephensen.;Chiwoneso B Tinago.;Kate A Ward.;Stephanie V Wrottesley.;George C Patton.
来源: Lancet. 2022年399卷10320期172-184页
During adolescence, growth and development are transformative and have profound consequences on an individual's health in later life, as well as the health of any potential children. The current generation of adolescents is growing up at a time of unprecedented change in food environments, whereby nutritional problems of micronutrient deficiency and food insecurity persist, and overweight and obesity are burgeoning. In a context of pervasive policy neglect, research on nutrition during adolescence specifically has been underinvested, compared with such research in other age groups, which has inhibited the development of adolescent-responsive nutritional policies. One consequence has been the absence of an integrated perspective on adolescent growth and development, and the role that nutrition plays. Through late childhood and early adolescence, nutrition has a formative role in the timing and pattern of puberty, with consequences for adult height, muscle, and fat mass accrual, as well as risk of non-communicable diseases in later life. Nutritional effects in adolescent development extend beyond musculoskeletal growth, to cardiorespiratory fitness, neurodevelopment, and immunity. High rates of early adolescent pregnancy in many countries continue to jeopardise the growth and nutrition of female adolescents, with consequences that extend to the next generation. Adolescence is a nutrition-sensitive phase for growth, in which the benefits of good nutrition extend to many other physiological systems.
4938. Nourishing our future: the Lancet Series on adolescent nutrition.
作者: George C Patton.;Lynnette M Neufeld.;Surabhi Dogra.;Edward A Frongillo.;Dougal Hargreaves.;Shanshan He.;Emily Mates.;Purnima Menon.;Mariam Naguib.;Shane A Norris.
来源: Lancet. 2022年399卷10320期123-125页 4940. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19.
|